Aseptic Meningitis

Enteroviral Assay Saves Hospital Costs When Prevalence is Above Breakeven Point

Published in TB and Outbreaks Week, October 17th, 2000

Two Harvard University researchers propose that by using a diagnostic strategy that incorporates enteroviral polymerase chain reaction (ePCR) testing on infants admitted to hospitals with elevated fevers and cerebrospinal fluid (CSF) pleocytosis (abnormal numbers of lymphocytes), substantial costs could be saved.

The researchers conducted a retrospective analysis of the potential cost savings that would be afforded a hospital if infants who are presumptively diagnosed with bacterial meningitis pending culture of CSF samples could be sent home earlier. The ePCR test would be used to rule out bacterial meningitis quicker.

According to L.E. Nigrovic...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2000-10-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry